Free eBooks & Special Reports
Blog Articles
- Is Heartburn Caused By “Leaky Esophagus”?
- Pills or Paleo? Reversing Heartburn and GERD
- The Dangers of Proton Pump Inhibitors
- 5 Causes of IBS Your Doctor May Not Be Looking For
Podcasts
- RHR: Overcoming Low Stomach Acid, Asthma, and Night Time Depression
- Ask the RD: Leg Cramping on Paleo and Laryngopharyngeal Reflux (LPR)
- RHR: Naturally Treating Heartburn, Infant Reflux, and Stroke Prevention
- RHR: How to Treat Acid Reflux in Babies Without Drugs
- RHR: New IBS-FODMAP Research, Overtraining and Acne, and Treating Alopecia Areata
- RHR: Gluten Triggered IBS-D, Twisted Food Politics, and Overcoming Histamine Intolerance
- RHR: New Treatment for SIBO and IBS-C—with Dr. Kenneth Brown
Studies
- A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity
- Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease
- Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis
- The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis
- The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis
- Profile of rifaximin and its potential in the treatment of irritable bowel syndrome
- Alteration of Gut Microbiota and Efficacy of Probiotics in Functional Constipation
- Profile of rifaximin and its potential in the treatment of irritable bowel syndrome
- The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
- Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders
- Clinical References for VSL#3
- Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn’s disease
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
- Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease
- Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn’s disease: a pilot study
- Is rifaximin effective in maintaining remission in Crohn’s disease?
- Rifaximin in the treatment of inflammatory bowel disease
- Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn’s disease
- Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Other Links
Previous TopicNext Topic